Cross-Border Impact Ventures
Venture fund that invested in TidalSense's round.
Cross-Border Impact Ventures, a Toronto-based, women-led impact investor, joined TidalSense's leaderless £14.2m funding round on 24 July 2026.
Last refreshed: 31 July 2026 · Appears in 1 active topic
Cross-Border Impact Ventures joined a round with no named lead; what does that say about the deal?
Timeline for Cross-Border Impact Ventures
Invested in TidalSense's round
UK Startups and Innovation: TidalSense takes £14.2m with no leadBackground
Cross-Border Impact Ventures is a Toronto-based, women-led impact venture capital firm focused on health technology, having closed its first fund above $90 million with a stated focus on women's and children's health.
Its investment in TidalSense, a Cambridge respiratory-diagnostics company, fits that health-technology mandate, backing a diagnostic device aimed at earlier, easier detection of chronic respiratory disease. The firm joined the round alongside BGF, Airstream Capital and Foresight Group, none of them named as lead investor.
Impact funds structured around health outcomes rather than pure financial return often participate in syndicates like this one, sharing risk with growth-equity investors rather than pricing and controlling a deal outright.